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INCREASED PERIOPERATIVE
MORTALITY IN ELECTIVE
CORONARYARTERY BYPASS
GRAFTING AFTER PREVIOUS
PERCUTANEOUS CORONARY
INTERVENTION
To the Editor:
The article by Bonaros and col-
leagues,1 which clearly establishes
the relationship between increased
perioperative complications and mor-
tality in patients with previous elective
percutaneous coronary intervention
(PCI) who underwent further elective
coronary artery bypass grafting
(CABG), reinforces the hypothesis
stemming from pathophysiologic
changes elicited by stent insertion.2
The study findings are very remark-
able, and some additional explanations
for these outcomes are offered herein.
The authors studied 306 consecutive
patients who underwent CABG after
previous elective PCI, and roughly one
third of the patients experienced myo-
cardial infarction (MI) at the interval
between PCI and CABG. Remarkably,
this finding has been unveiled in the
meta-analysis of randomized trials com-
paring PCI with conservative medical
treatment in patients with stable coro-
nary artery disease by Katritsis and
Ioannidis,3 in which there was a trend
for more nonfatal MI in patients who
underwent PCI, suggesting an approxi-
mately 30% increase in the relative risk
of nonfatal MI with PCI. Coronary
stenting appears to cause an intense
and sustained coronary artery inflam-
matory response in the vessel wall,
and a large body of evidence links in-
flammatory mechanisms to atheroma-
tous plaque destabilization, leading to
plaque rupture and coronary events.
Furthermore, ejection fraction was
found to be lower in the PCI group
when compared with that seen in the
non-PCI group. Apart from the higher
rate of MI in the PCI group, periproce-
dural PCI-induced myocardial injury
might play an important role in this
outcome, with an acute ischemic pro-
cess triggered by several factors related
to the stent implantation procedure.2
An approximately 4-fold increase in
the incidence of perioperative MI was
observed in the PCI group, which was
associated with a significantly higher
incidence of low cardiac output syn-
drome and perioperativemortality com-
pared with that seen in the non-PCI
group. In this particular aspect one can-
not neglect the role of a PCI-induced
sustained inflammatory reaction lead-
ing to perennial endothelial dysfunc-
tion, inducing stent thrombosis, and,
more importantly, adversely affecting
early and long-term graft patency. This
issue remains significantly overlooked,
and further studies are urgently required
to elucidate this question.
Therefore data from the study by
Bonaros and colleagues1 help to sub-
stantiate and unquestionably justify
the former premise that CABG might
not provide equivalent outcomes in
patients with previous stenting.
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Gomes1 hypothesizes that percutane-
ous coronary interventions (PCIs) with
coronary stents aggravate local and sys-
temic inflammatory reactions, which
might be responsible for major coronary
events, such as plaque rupture and
myocardial infarction. Based on our
findings, 33% of the patients studied
had a history of myocardial infarction
during the interval between PCI and cor-
onary artery bypass grafting.2 Accord-
ing to the results of the SYNTAX trial,
4.4% of the patients treated with PCI
had a periprocedural major adverse car-
diac event.3 Long-term events could be
attributed to stent thrombosis as a result
of inflammatory reaction, insufficient
antiplatelet therapy, or resistance to clo-
pidogrel therapy, aspirin therapy, or
both.4 Although more than one third of
the patients undergoingPCIwere treated
with drug-eluting stents, the incidence of
target lesion revascularization was quite
high (19%) in these series. A local in-
flammatory reaction can result in platelet
and leukocyte activation, as well as
plaque destabilization, the effects of
whichmight extend to the target vessel.5
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conclude that statins do retard the pro-
gression of aortic stenosis by retarding
the increase in peak aortic jet velocity
(PAJV) but not reducing the decrease
in aortic valve area (AVA). The recent
publication of the Simvastatin and
Ezetimibe in Aortic Stenosis (SEAS)
study2 prompted us to do a meta-
analysis on the same question to see
pressed as percentage change per year,
whereas for the rest of the studies, the
PAJV was in meters per second per
year, and for AVA, it was in square me-
ters per year. Itwas almost impossible to
create a Forrest plot with their data, and
the percentage data became huge and
far away from the rest of the studies,
which became almost invisible dots in
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To the Editor:
The meta-analysis by Takagi and
coworkers1 addresses the effect of sta-
tins on aortic stenosis. The authors
whether there is any difference in the
summary estimate. During this pro-
cess, we realized that there were
some errors in the calculation of the
summary estimate. In brief, the units
had been mixed in the calculations.
The data for AVA and PAJV for the
Bellamy3 and Mohler4 studies were ex-
the figure. This must have prompted
the authors to use the standardized
mean difference in figures.
We corrected this mistake by projec-
ting the AVA and PAJV change per
year using the baseline values and per-
centage change data expressed in the
original articles (Figures 1 and 2).
FIGURE 1. Annualized increase in peak aortic jet velocity (PAJV; mean difference).
FIGURE 2. Annualized decrease in aortic valve area (AVA; mean difference).
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